[ad_1]
Ssecond advances the news agency EFE, a CSL It clarified that, although no adverse effects were observed in phase 1 trials, it began in July 216 people participated in the past, scientific data revealed that the antibodies developed in this process interfered with the diagnosis of HIV, paving the way for “false positives”.
In a statement to the Australian Stock Exchange (ASX) to announce this decision, which was made with the Australian government, the director scientific CSLAndrew Nash stressed that in the initial development of a vaccine there is always a “risk of failure.”
Further development of the UQ / vaccineCSL v451, which was shown in phase 1 to have “a strong response” to the new coronavirusas well as ‘a robust safety profile’ would require significant changes in the draftexperts admit.
“This was going to delay the draft 12 months or more. It was a very difficult decision adoptbut at present there is an urgent need to have a vaccine and that is the priority ”, commented Paul Young, one of the leaders of the draft vaccine from the University of Queensland.
Following the decision, Australian Prime Minister Scott Morrison testified in Canberra, that his government authorized an increase from 33.8 million to 53.8 million doses of the vaccine AstraZeneca/ Oxford and 40 to 51 million doses of the vaccine Novavax.
“Vaccines AstraZeneca will of course be produced by CSL in Melbourne, “Morrison said, insisting that” health and safety have been the starting point for all responses to pandemic COVID-19-19. “.
The Australian government, which planned to supply the vaccine. COVID-19-19 from March, also has an agreement with BioNtech-Pfizer, to acquire and transport 10 million of this vaccine, which needs to be kept at 70 degrees below zero.
Australia, where he was assigned emphasis to systems tracking, has accumulated almost 28 thousand infections since the beginning of pandemic, including 908 deaths, the majority due to the outbreak in Melbourne.
Always be the first to know.
Follow the chosen site for the fourth consecutive year Consumer Choice.
Download our free app.
[ad_2]
